ANI PHARMACEUTICALS, INC Cash and Cash Equivalents
ANI PHARMACEUTICALS, INC (ANIP) had Cash and Cash Equivalents of $360.21 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-07
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $360.21M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $311.18M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $285.58M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $262.61M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $360.21M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $311.18M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $285.58M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $262.61M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $217.83M 10-Q · filed 2026-08-07 | $217.80M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $149.80M 10-Q · filed 2026-05-08 | |
| 2024-12-31 | $144.89M 10-Q · filed 2026-08-07 | $144.86M 10-K · filed 2025-02-28 |
| 2024-09-30 | $144.98M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $240.11M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $228.60M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $221.12M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $193.08M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $161.71M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $67.76M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $48.23M 10-K · filed 2026-02-27 | |
| 2022-09-30 | $56.28M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $63.38M 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $76.91M 10-Q · filed 2023-05-08 | |
| 2021-12-31 | $100.30M 10-K · filed 2025-02-28 | |
| 2021-09-30 | $15.25M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $24.26M 10-Q · filed 2022-08-08 | |
| 2021-03-31 | $25.07M 10-Q · filed 2022-05-10 | |
| 2020-12-31 | $7.86M 10-K · filed 2024-02-29 | |
| 2020-09-30 | $17.90M 10-Q · filed 2021-11-01 | |
| 2020-06-30 | $27.70M 10-Q · filed 2021-08-06 | |
| 2020-03-31 | $20.41M 10-Q · filed 2021-05-07 | |
| 2019-12-31 | $62.33M 10-K · filed 2023-03-09 | |
| 2019-09-30 | $59.67M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $40.59M 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $38.23M 10-Q · filed 2020-05-07 | |
| 2018-12-31 | $43.01M 10-K · filed 2022-03-15 | |
| 2018-09-30 | $44.14M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $54.99M 10-Q · filed 2019-08-07 | |
| 2018-03-31 | $51.97M 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $31.14M 10-K · filed 2021-03-11 | |
| 2017-09-30 | $18.03M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $8.37M 10-Q · filed 2018-08-07 | |
| 2017-03-31 | $10.83M 10-Q · filed 2018-05-08 | |
| 2016-12-31 | $27.36M 10-K · filed 2020-02-27 | |
| 2016-09-30 | $16.16M 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $15.01M 10-Q · filed 2017-08-03 | |
| 2016-03-31 | $77.75M 10-Q · filed 2017-05-04 | |
| 2015-12-31 | $154.68M 10-K · filed 2019-02-27 | |
| 2015-09-30 | $150.91M 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $166.73M 10-Q · filed 2016-08-04 | |
| 2015-03-31 | $165.56M 10-Q · filed 2016-05-05 | |
| 2014-12-31 | $169.04M 10-K · filed 2018-02-27 | |
| 2014-09-30 | $35.05M 10-Q · filed 2015-11-03 | |
| 2014-06-30 | $52.96M 10-Q · filed 2015-08-04 | |
| 2014-03-31 | $51.37M 10-Q · filed 2015-05-05 | |
| 2013-12-31 | $11.11M 10-K · filed 2017-03-02 | |
| 2013-09-30 | $10.93M 10-Q · filed 2014-11-10 | $10.93M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $12.60M 10-Q · filed 2014-08-07 | $12.59M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $41.00K 10-Q · filed 2014-05-12 | $29.39M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $11.00K 10-K · filed 2016-02-23 | $34.79M 10-K · filed 2013-02-28 |
| 2012-09-30 | $148.33K 10-Q · filed 2013-11-07 | $38.05M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $119.62K 10-Q · filed 2013-08-09 | $42.42M 10-Q · filed 2012-08-01 |
| 2012-03-31 | $49.47M 10-Q · filed 2013-05-10 | |
| 2011-12-31 | $0.00 10-K · filed 2014-02-28 | $57.23M 10-K · filed 2012-03-13 |
| 2011-09-30 | $69.60M 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $37.13M 10-Q · filed 2012-08-01 | |
| 2011-03-31 | $51.35M 10-Q · filed 2012-05-08 | |
| 2010-12-31 | $38.16M 10-K · filed 2013-02-28 | |
| 2010-09-30 | $35.53M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $46.38M 10-Q · filed 2011-08-05 | |
| 2009-12-31 | $29.86M 10-K · filed 2013-02-28 | |
| 2008-12-31 | $11.76M 8-K · filed 2013-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |